Summary
In 42 tumour samples of human neuroblastoma, histological classification by differentiation (Shimada) was significantly correlated with strong positivity for neuron-specific enolase (NSE) and inversely correlated with rosette formation. Most ganglioneuroblastomas were positive for S-100 protein and reacted strongly with NSE antibody. Histological signs of high proliferative activity included intermediate or high mitosis-karyorrhexis index, necrosis and lack of calcification, which were significantly correlated with each other. Flow cytometric DNA analysis demonstrated that 88% of the tumour samples had DNA aneuploid stem lines. High S phase fraction (>-0.20) was significantly correlated with necrosis and lack of calcification. Univariate analysis of prognosis for 26 patients whose tumour samples were obtained before adjuvant treatment showed that five factors were significantly related to a better outcome: early stage of the disease (stages I, II, IV-S), S phase fraction <0.20, favourable Shimada histology, positivity for S-100 protein, and strong positivity for NSE. In multivariate analysis, only S phase fractionor stage of disease remained significantly associated with prognosis. DNA index did not correlate with prognosis in this study.
Similar content being viewed by others
References
Alanen KA, Joensuu H, Klemi PJ (1989) Autolysis is a potential source of false aneuploid peaks in flow cytometric DNA histograms. Cytometry 10:417–425
Anderson JR, Cain KC, Gelber RD, Gelman RS (1985) Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials. Cancer Treat Rep 69:1139–1146
Aoyama C, Qualman SJ, Regan M, Shimada H (1990) Histopathologic features of composite ganglioneuroblastoma. Cancer 65:255–264
Beckwith JB, Martin RF (1968) Observations on the histopathology of neuroblastomas. J Pediatr Surg 3:106–110
Biedler JL, Reynolds CP, Ross RA, Mirkin BL, Tsunamoto K, Sugimoto T, Boyd JP (1988) Discussion. In: Evans AE, D'Angio GJ, Knudson AG, Seeger RC (eds) Advances in neuroblastoma research 2. Liss, New York, pp 359–375
Bourhis J, De Vathaire F, Wilson GD, Hartman O, Terrier-Lacombe MJ, Boccon-Gibod L, McNally NJ, Lemerle J, Riou G, Bénard J (1991) Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res 51:33–36
Brenner DW, Barranco SC, Winslow BH, Shaeffer J (1989) Flow cytometric analysis of DNA content in children with neuroblastoma. J Pediatr Surg 24:204–207
Breslow N, McCann B (1971) Statistical estimation of prognosis for children with neuroblastoma. Cancer Res 31:2098–2103
Brodeur GM, Fong C-t (1989) Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 41:153–174
Brown P de Nully, Hertz H, Olsen JH, Yssing M, Scheibel E, Jensen OM (1989) Incidence of childhood cancer in Denmark 1943-1984. Int J Epidemiol 18:546–555
Carlei F, Polak JM, Ceccamea A, Marangos PJ, Dahl D, Cocchia D, Michetti F, Lezoche E, Speranza V (1984) Neuronal and glial markers in tumours of neuroblastic origin. Virchows Arch [A] 404:313–324
Carlsen NLT (1991a) Maturation of neuroblastoma. Eur J Cancer 27:219
Carlsen NLT (1991b) Prognostic factors in neuroblastomas of childhood. Current problems. Pediatr Rev Commun 6:63–77
Carlsen NLT, Nielsen OH, Hertz H (1981) Neuroblastoma. Acta Paediatr Scand 70:61–66
Carlsen NLT, Christensen IJ, Schroeder H, Bro PV, Erichsen G, Hamborg-Pedersen B, Jensen KB, Nielsen OH (1986) Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980. Cancer 58:2726–2735
Carlsen NLT, Mortensen BT, Andersson PK, Larsen JK, Nielsen OH, Tommerup N (1991) Chromosome abnormalities, cellular DNA content, oncogene amplification, and growth pattern in agar culture of human neuroblastoma. Anticancer Res 11:353–358
Christensen I, Hartmann NR, Keiding N, Larsen JK, Noer H, Vindetøv L (1978) Statistical analysis of DNA distribution from cell populations with partial synchrony. In: Lutz D (ed) Pulsecytophotometry III. European Press, Ghent, pp 71–78
Cohn SL, Rademaker AW, Salwen HR, Franklin WA, Gonzales-Crussi F, Rosen ST, Bauder KD (1990) Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma. Am J Pathol 136:1043–1052
Coldman AJ, Fryer CJH, Elwood JM, Sonley MJ (1980) Neuroblastoma: influence of age at diagnosis, stage, tumor site, and sex on prognosis. Cancer 46:1896–1901
Dargeon HW (1962) Neuroblastoma. J Pediatr 61:456–471
Evans AE, D'Angio GJ, Propert K, Anderson J, Hann H-WL (1987) Prognostic factors in neuroblastoma. Cancer 59:1853–1859
Evans AE, D'Angio GJ, Sather HN, deLorimier AA, Dalton A, Ungerleider RS, Finklestein JZ, Hammond GD (1990) A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group. J Clin Oncol 8:678–688
Gansler T, Chatten J, Varello M, Bunin GR, Atkinson B (1986) Flow cytometric DNA analysis of neuroblastoma. Correlation with histology and clinical outcome. Cancer 58:2453–2458
Gitlow SE, Dziedzic LB, Strauss L, Greenwood SM, Dziedzic SW (1973) Biochemical and histologic determinants in the prognosis of neuroblastoma. Cancer 32:898–905
Haase GM, Wong KY, deLorimier AA, Sather HN, Hammond GD (1989) Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg 24:194–200
Hayashi Y, Kanda N, Inaba T, Hanada R, Nagahara N, Muchi H, Yamamoto K (1989) Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63:126–132
Horn RC, Koop CE, Kiesewetter WB (1956) Neuroblastoma in childhood. Clinicopathologic study of forty-four cases. Lab Invest 5:106–119
Hughes M, Marsden HB, Palmer MK (1974) Histologic patterns of neuroblastoma related to prognosis and clinical staging. Cancer 34:1706–1711
Kaneko Y, Kanda N, Maseki N, Sakurai M, Tsuchida Y, Takeda T, Okabe I, Sakurai M (1987) Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res 47:311–318
Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA (1984) Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 311:231–235
Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith El, Brodeur GM (1991) Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 9:581–591
Mäkinen J (1972) Microscopic patterns as a guide to prognosis of neuroblastoma in childhood. Cancer 29:1637–1646
Matthay KK, Sather HN, Seeger RC, Haase GM, Hammond GD (1989) Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7:236–244
Molenaar WM, Baker DL, Pleasure D, Lee V M-Y, Trojanowski JQ (1990) The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas. Am J Pathol 136:375–382
Nitschke R, Smith EI, Shochat S, Altshuler G, Travers H, Shuster JJ, Hayes FA, Patterson R, McWilliams N (1988) Localized neuroblastoma treated by surgery: a Pediatric Oncology Group study. J Clin Oncol 6:1271–1279
O'Neill JA, Littman P, Blitzer P, Soper K, Chatten J, Shimada H (1985) The role of surgery in localized neuroblastoma. J Pediatr Surg 20:708–712
Oppedal BR, Storm-Mathisen I, Lie SO, Brandtzaeg P (1988) Prognostic factors in neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis. Cancer 62:772–780
Ornvold K, Carstensen H, Larsen JK, Christensen IJ, Ralfkiaer E (1990) Flow cytometric DNA analysis of lesions from 18 children with Langerhans cell histiocytosis (Histiocytosis X). Am J Pathol 136:1301–1307
Sandstedt B, Jereb B, Eklund G (1983) Prognostic factors in neuroblastomas. APMIS 91:365–371
Schutte B, Reynders MMJ, Bosman FT, Blijham GH (1985) Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 6:26–30
Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi AB, Chiba T, Marsden HB, Misugi K (1984) Histopathologic prognostic factors in neuroblastic tumors: definitions of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405–416
Shimada H, Aoyama C, Chiba T, Newton WA (1985) Prognostic subgroups for undifferentiated neuroblastoma: immunohisto-chemical study with anti-S-100 protein antibody. Hum Pathol 16:471–476
Slavc I, Ellenbogen R, Jung W-H, Vawter GF, Kretschmar C, Grier H, Korf BR (1990)Myc gene amplification and expression in primary human neuroblastoma. Cancer Res 50:1459–1463
Suzuki H, Takeuchi K, Honzumi M (1989) Letter to the Editor. J Pediatr Surg 24:850
Taylor SR, Locker J (1990) A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma. Cancer 65:1360–1366
Taylor SR, Blatt J, Costantino JP, Roederer M, Murphy RF (1988) Flow cytometric DNA analysis of neuroblastoma. A 10-year retrospective study. Cancer 62:749–754
Thomas PRM, Lee JY, Fineberg BB, Razek AA, Perez CA, Land VJ, Vietti TJ (1984) An analysis of neuroblastoma at a single institution. Cancer 53:2079–2082
Tsuda T, Obara M, Hirano H, Gotoh S, Kubomura S, Higashi K, Kuroiwa A, Nakagawara A, Nagahara N, Shimizu K (1987) Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas. Cancer 60:820–826
Vindeløv LL, Christensen IJ (1990) A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry 11:753–770
Wilson LMK, Draper GJ (1974) Neuroblastoma, its natural history and prognosis: a study of 487 cases. BMJ 3:301–307
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carlsen, N.L.T., Ørnvold, K., Christensen, I.J. et al. Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas. Vichows Archiv A Pathol Anat 420, 411–418 (1992). https://doi.org/10.1007/BF01600512
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01600512